Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial

EdwardClarke; (2021) Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Infectious Diseases. ISSN 1473-3099 DOI: 10.1016/S1473-3099(20)30735-0.

Copy

Item Type	Article
Elements ID	155927
Official URL	https://www.thelancet.com/journals/laninf/article/...

Atom

BibTeX

OpenURL ContextObject in Span

Multiline CSV

OpenURL ContextObject

Dublin Core

MPEG-21 DIDL

EndNote

HTML Citation

JSON

MARC (ASCII)

MARC (ISO 2709)

METS

MODS

RDF+N3

RDF+N-Triples

RDF+XML

RIOXX2 XML

Reference Manager

Refer

Simple Metadata

ASCII Citation

EP3 XML

Export

Downloads

picture_as_pdf: Phase 3 Pneumosil Lancet ID.pdf
subject: Published Version
: Available under Creative Commons: NC-ND 3.0

View

Download

Explore Further

Find work associated with the faculties and division(s):

GM-Vaccinology Theme

Find work from this publication:

Lancet Infectious Diseases